搜索临床试验以:YY-162
总计3063个结果
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知套细胞淋巴瘤 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 小淋巴细胞淋巴瘤
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知
-
Ruijin HospitalTianjin Medical University Cancer Institute and Hospital尚未招聘
-
University of CopenhagenEC-FP6 (contract number: LHM-CT-2003-503041); Aditech Pharma AB完全的
-
Shanghai YingLi Pharmaceutical Co. Ltd.招聘中
-
Shanghai YingLi Pharmaceutical Co. Ltd.未知
-
M.D. Anderson Cancer CenterArray BioPharma终止
-
Beijing Shenogen Biomedical Co., Ltd307 Hospital of PLA; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Qingdao... 和其他合作者完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Cancer Institute and Hospital, Chinese Academy...Beijing Shenogen Biomedical Co., Ltd完全的
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤 | 难治性多发性骨髓瘤美国
-
Cancer Institute and Hospital, Chinese Academy...Beijing Shenogen Biomedical Co., Ltd未知
-
Beijing Shenogen Biomedical Co., LtdThe First Affiliated Hospital with Nanjing Medical University; Guilin Medical University, China 和其他合作者未知
-
M.D. Anderson Cancer CenterArray BioPharma终止
-
Northwestern UniversityNational Cancer Institute (NCI); Amgen终止IV 期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | 乳腺癌骨转移 | 循环肿瘤细胞计数美国